MedAssets remains a Top Pick, says RW Baird Baird continues to view MedAssets as a Top Pick ahead of Q4 results. The firm expects an inline quarter and guidance but sees reaccelerating results in the second half of 2014 and beyond. Shares are Outperform rated with a $28 price target.
News For MDAS From The Last 14 Days
Check below for free stories on MDAS the last two weeks.